Access cutting-edge migraine treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access migraine specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related migraine treatment provided free
This is a multicenter, randomized, double-blind, placebo-controlled, 3-period crossover study to evaluate the safety, tolerability, and efficacy of two dose levels of K-645 in the treatment of patients with acute migraine.
Sponsor: Kallyope Inc.
Check if you qualify for this migraine clinical trial in Atlanta, GA
If you're searching for migraine treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.